See more : Madison Square Garden Entertainment Corp. (MSGE) Income Statement Analysis – Financial Results
Complete financial analysis of Dirui Industrial Co.,Ltd. (300396.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dirui Industrial Co.,Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Columbia Sportswear Company (COLM) Income Statement Analysis – Financial Results
- Capella Minerals Limited (CMIL.V) Income Statement Analysis – Financial Results
- PepperLime Health Acquisition Corporation (PEPLU) Income Statement Analysis – Financial Results
- Trinity Industrial Corporation (6382.T) Income Statement Analysis – Financial Results
- ZW Data Action Technologies Inc. (CNET) Income Statement Analysis – Financial Results
Dirui Industrial Co.,Ltd. (300396.SZ)
About Dirui Industrial Co.,Ltd.
Dirui Industrial Co.,Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments, diagnostic reagents, test strips, etc. It offers biochemical blood cell, urine, coagulation, chemiluminescence immunoassay, and gynecological secretion analyzers. The company was founded in 1992 and is headquartered in Changchun, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.36B | 1.22B | 905.80M | 937.24M | 1.01B | 933.42M | 867.69M | 758.69M | 567.33M | 486.47M | 464.40M | 413.63M | 358.06M | 231.19M | 175.65M |
| Cost of Revenue | 681.68M | 585.74M | 431.80M | 415.10M | 358.77M | 325.68M | 309.90M | 283.71M | 233.73M | 214.74M | 204.92M | 183.48M | 167.54M | 115.76M | 100.78M |
| Gross Profit | 681.64M | 634.27M | 473.99M | 522.13M | 650.03M | 607.74M | 557.79M | 474.99M | 333.59M | 271.73M | 259.49M | 230.16M | 190.51M | 115.43M | 74.87M |
| Gross Profit Ratio | 50.00% | 51.99% | 52.33% | 55.71% | 64.44% | 65.11% | 64.28% | 62.61% | 58.80% | 55.86% | 55.87% | 55.64% | 53.21% | 49.93% | 42.63% |
| Research & Development | 128.63M | 114.82M | 95.03M | 95.99M | 107.55M | 102.27M | 83.83M | 73.49M | 50.09M | 46.72M | 35.51M | 34.09M | 25.04M | 0.00 | 0.00 |
| General & Administrative | 33.03M | 23.59M | 13.40M | 15.31M | 13.25M | 14.05M | 12.59M | 16.95M | 15.41M | 7.56M | 8.64M | 8.78M | 4.58M | 29.39M | 28.15M |
| Selling & Marketing | 100.12M | 182.96M | 135.59M | 121.58M | 141.42M | 145.19M | 151.00M | 138.42M | 102.76M | 82.44M | 80.00M | 72.80M | 61.59M | 38.53M | 25.26M |
| SG&A | 310.76M | 206.55M | 148.98M | 136.89M | 154.67M | 159.25M | 163.59M | 155.36M | 118.17M | 89.99M | 88.64M | 81.59M | 66.16M | 67.92M | 53.41M |
| Other Expenses | -52.22M | 44.38M | 30.59M | 53.15M | 88.56M | 6.85M | 13.30M | 27.93M | 23.25M | 20.40M | 14.06M | 13.46M | 9.02M | 7.03M | 2.98M |
| Operating Expenses | 387.16M | 365.75M | 274.61M | 286.03M | 350.78M | 341.56M | 326.37M | 319.40M | 229.16M | 179.03M | 158.38M | 138.78M | 106.41M | 69.33M | 54.50M |
| Cost & Expenses | 1.08B | 951.49M | 706.41M | 701.13M | 709.55M | 667.24M | 636.27M | 603.11M | 462.89M | 393.77M | 363.30M | 322.25M | 273.95M | 185.08M | 155.28M |
| Interest Income | 29.54M | 14.83M | 8.71M | 10.59M | 8.81M | 4.53M | 2.34M | 4.40M | 9.78M | 5.12M | 1.69M | 808.68K | 286.09K | -0.74 | -0.31 |
| Interest Expense | 10.97M | 6.14M | 4.45M | 3.10M | 2.91M | 4.69M | 6.48M | 10.75M | 306.31K | 4.72M | 126.46K | 2.20M | 1.92M | 1.61M | 1.10M |
| Depreciation & Amortization | 42.68M | 37.91M | 35.71M | 57.46M | 71.36M | 66.77M | 63.04M | 57.02M | 30.33M | 16.77M | 14.17M | 9.69M | 7.14M | 6.15M | 7.11M |
| EBITDA | 345.56M | 311.39M | 268.47M | 365.85M | 384.53M | 347.65M | 313.13M | 249.39M | 167.53M | 131.48M | 120.67M | 107.95M | 97.19M | 52.26M | 27.48M |
| EBITDA Ratio | 25.35% | 28.79% | 30.40% | 40.01% | 38.24% | 37.47% | 36.56% | 33.00% | 30.72% | 27.93% | 27.59% | 27.70% | 27.76% | 23.19% | 16.17% |
| Operating Income | 296.87M | 292.18M | 230.13M | 309.53M | 303.32M | 268.73M | 229.46M | 153.92M | 113.94M | 94.61M | 91.85M | 82.28M | 79.14M | 60.77M | 18.37M |
| Operating Income Ratio | 21.78% | 23.95% | 25.41% | 33.03% | 30.07% | 28.79% | 26.44% | 20.29% | 20.08% | 19.45% | 19.78% | 19.89% | 22.10% | 26.29% | 10.46% |
| Total Other Income/Expenses | -678.02K | -741.76K | -1.00M | -4.86M | 6.37M | 6.85M | 13.30M | 27.91M | 22.95M | 20.10M | 14.06M | 13.42M | 8.99M | 7.02M | 2.95M |
| Income Before Tax | 296.20M | 291.44M | 229.13M | 312.73M | 309.68M | 275.58M | 242.76M | 181.11M | 136.89M | 114.71M | 105.91M | 95.69M | 88.13M | 67.79M | 21.32M |
| Income Before Tax Ratio | 21.73% | 23.89% | 25.30% | 33.37% | 30.70% | 29.52% | 27.98% | 23.87% | 24.13% | 23.58% | 22.81% | 23.13% | 24.61% | 29.32% | 12.14% |
| Income Tax Expense | 20.62M | 29.73M | 19.18M | 27.99M | 36.80M | 35.62M | 31.63M | 23.59M | 16.95M | 13.35M | 12.31M | 11.47M | 11.82M | 7.56M | 2.41M |
| Net Income | 275.59M | 261.83M | 209.95M | 267.07M | 231.89M | 197.73M | 167.39M | 125.14M | 108.28M | 101.36M | 93.61M | 84.22M | 76.31M | 60.39M | 18.71M |
| Net Income Ratio | 20.21% | 21.46% | 23.18% | 28.50% | 22.99% | 21.18% | 19.29% | 16.49% | 19.09% | 20.84% | 20.16% | 20.36% | 21.31% | 26.12% | 10.65% |
| EPS | 1.01 | 0.96 | 0.77 | 0.97 | 0.85 | 0.72 | 0.61 | 0.45 | 0.39 | 0.45 | 0.45 | 0.41 | 0.37 | 0.31 | 0.14 |
| EPS Diluted | 1.01 | 0.95 | 0.77 | 0.97 | 0.85 | 0.72 | 0.61 | 0.45 | 0.39 | 0.45 | 0.45 | 0.41 | 0.37 | 0.31 | 0.14 |
| Weighted Avg Shares Out | 272.86M | 272.63M | 274.12M | 274.12M | 274.27M | 276.00M | 276.03M | 276.03M | 274.51M | 225.24M | 207.51M | 207.09M | 206.87M | 196.92M | 135.79M |
| Weighted Avg Shares Out (Dil) | 272.86M | 275.50M | 274.12M | 274.12M | 274.27M | 276.00M | 276.04M | 276.04M | 274.51M | 225.24M | 207.51M | 207.10M | 206.87M | 196.92M | 135.79M |
Source: https://incomestatements.info
Category: Stock Reports